Innovating.works Conecta tu I+D

MDOT: Medical Device Obligations Taskforce UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un H2020: H2020-NMBP-TO-IND-2018-2020 The new Medical Device Regulation (MDR) bears the potential to hamper Europe’s innovation competitiveness since reiterated, widened testing...
2018-12-19 - 2024-06-30 | Financiado

IMPROVE-PD: Identification and Management of Patients at Risk Outcome and Vascular Events in Peritoneal Dialys... UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un H2020: H2020-MSCA-ITN-2018 Peritoneal dialysis (PD) is an underused life saving renal replacement therapy for end-stage kidney disease. Nevertheless, PD patients remai...
2018-09-13 - 2023-06-30 | Financiado

ORBIS: Open Research Biopharmaceutical Internships Support UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU tramitó un H2020: H2020-MSCA-RISE-2017 The current process of drug development is lengthy and inefficient. Only 1 out of approximately 10,000 drug molecules enters the market. The...
2017-10-06 - 2023-08-31 | Financiado

EUROlinkCAT: EUROlinkCAT Establishing a linked European Cohort of Children with Congenital Anomalies UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un H2020: H2020-SC1-2016-2017 Over 130,000 children born in Europe every year will have a congenital anomaly (CA; birth defect). These CAs, which are often rare diseases,...
2016-12-12 - 2022-05-31 | Financiado

ALBINO: Effect of ALlopurinol in addition to hypothermia for hypoxic ischemic Brain Injury on Neurocognitive... UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un H2020: H2020-PHC-2014-2015 Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of death or long-term disability in infants born at term in the western worl...
2015-12-09 - 2025-06-30 | Financiado

SHIPS: Screening to improve Health In very Preterm infantS in Europe UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un H2020: H2020-PHC-2014-2015 Very preterm birth is a principal determinant of motor and cognitive impairment in later life. About 50 000 infants in the EU survive very p...
2015-04-09 - 2019-01-31 | Financiado

ENRICHME: Enabling Robot and assisted living environment for Independent Care and Health Monitoring of the Eld... UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un H2020: H2020-PHC-2014-2015 ENRICHME tackles the progressive decline of cognitive capacity in the ageing population proposing an integrated platform for Ambient Assiste...
2015-02-03 - 2018-02-28 | Financiado

OPTIMISE: OPtimization of Treatment and Management of Schizophrenia in Europe OPTiMiSE UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) will focus on two goals: optimising current treatments in Sch...
Financiado

EUTRIPD: European Training and Research in Peritoneal Dialysis UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: Peritoneal dialysis (PD) and haemodialysis (HD) are life-saving renal replacement therapies for more than 200,000 patients with chronic kidn...
Financiado

DALI: Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus GDM Prevention UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: Europe is facing a rapidly growing threat from Type 2 diabetes mellitus (T2D), which is undoubtedly associated with an unhealthy diet and a...
Financiado

IMPACT: IMplementation of quality indicators in PAlliative Care sTudy UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: New knowledge is not necessarily readily applied in medicine, even when there is evidence of its effectiveness. As a result of the gap betwe...
Financiado

EUROMEDICAT: EUROmediCAT Safety of Medication use in Pregnancy in Relation to Risk of Congenital Malformations UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: A variety of complementary approaches are needed to evaluate safety of medicine use in pregnancy. To evaluate safety in relation to teratoge...
Financiado

PROTECT: Pharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTium UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: Recent pharmacovigilance (PV) issues have led to questions regarding the ability of the current PV system to meet the global needs. Controve...
Financiado

EPICE: Effective Perinatal Intensive Care in Europe translating knowledge into evidence based practice UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: Context: Very preterm infants face high risks of mortality and long-term neuro-developmental impairment. Rates of mortality and morbidity va...
Financiado

CHERISH: Improving Diagnoses of Mental Retardation in Children in Central Eastern Europe and Central Asia t... UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: Mental retardation (MR) is a highly heterogeneous disorder and is of genetic origin in about 50% of the cases. Despite recent progress in re...
Financiado

NANOMINING: Development of new nanocomposites using materials from mining industry UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIU participó en un FP7: Silver nanoparticles and silver based nanostructured composites are being frequently used in a variety of biomedical and industrial appli...
Financiado

POZNAN UNIVERSITY OF MEDICAL SCIENCES